Nadroparin (Ca) (Nadroparin (Ca))
Overview of Nadroparin (Ca)
Nadroparin (Ca) is a low molecular weight heparin with anti-coagulant properties.Nadroparin (Ca) is used in the treatment and prophylaxis of venous thrombo-embolism and to prevent clotting during extracorporeal circulation.
Indication of Nadroparin (Ca)
Nadroparin (Ca) is primarily indicated in conditions like Prophylaxis of thrombosis, Pulmonary embolism, Thromboembolism, and can also be given in adjunctive therapy as an alternative drug of choice in Unstable angina.
Contraindication of Nadroparin (Ca)
Nadroparin (Ca) is contraindicated in conditions like Diabetic retinopathy,Severe uncontrolled hypertension,Hypersensitivity to any component of product.
Side Effects of Nadroparin (Ca)
The signs and symptoms that are produced after the acute overdosage of Nadroparin (Ca) include Hemorrhage.,The symptomatic adverse reactions produced by Nadroparin (Ca) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Rashes, Allergic reactions, Thrombocytopenia, Bleeding, Pain at injection site, Hypoaldosteronism, Injection site hematoma.
Precautions of Nadroparin (Ca)
Patients with recent or anticipated neuraxial anesthesia (epidural or spinal anesthesia) are at risk of spinal or epidural hematoma and subsequent paralysis. Patient should be closely monitored for sighns or symptoms of bleeding.Should be use with caution in patients with severe hepatic or renal disease. Safety and efficacy in pediatric patients have not been established. Should not be used interchangeably (unit for unit) with heparin or any other low molecular weight heparins.